IVZ Stock Analysis: | NYSE

Asset Management | NYSE, USA | Market Cap: 12.605m USD | 12M Return: 23.7% | BMG491BT1088 | Charts, Fundamentals & Technical Analysis

Mutual Funds, Exchange-Traded Funds, Equity Portfolios, Fixed Income
Total Rating 40
Safety 42
Buy Signal -0.47
Asset Management
Industry Rotation: +0.9
Market Cap: 12.6B
Avg Turnover: 145M
Risk 3d forecast
Volatility36.1%
VaR 5th Pctl6.24%
VaR vs Median4.99%
Reward TTM
Sharpe Ratio0.68
Rel. Str. IBD57
Rel. Str. Peer Group72.5 pctl
Character TTM
Beta1.835
Beta Downside1.756
Hurst Exponent0.403
Choppyness51.5%
Drawdowns 3y
Max DD36.52%
CAGR/Max DD0.95
CAGR/Mean DD4.08
EPS (Earnings per Share) EPS (Earnings per Share) of IVZ over the last years for every Quarter: "2021-09": 0.77, "2021-12": 0.86, "2022-03": 0.56, "2022-06": 0.39, "2022-09": 0.34, "2022-12": 0.39, "2023-03": 0.38, "2023-06": 0.31, "2023-09": 0.35, "2023-12": 0.47, "2024-03": 0.33, "2024-06": 0.43, "2024-09": 0.44, "2024-12": 0.52, "2025-03": 0.44, "2025-06": 0.36, "2025-09": 0.61, "2025-12": 0.62, "2026-03": 0.57, "2026-06": 0.71, "2026-09": 0.72,
EPS CAGR: 22.33%
EPS Trend: 96.7%
Last SUE: -0.48
Qual. Beats: 0
Revenue Revenue of IVZ over the last years for every Quarter: 2021-09: 1750, 2021-12: 1763.4, 2022-03: 1629.4, 2022-06: 1530.4, 2022-09: 1445.7, 2022-12: 1443.4, 2023-03: 1418.2, 2023-06: 1442.8, 2023-09: 1442, 2023-12: 1413.4, 2024-03: 1475.3, 2024-06: 1483.3, 2024-09: 1515.4, 2024-12: 1593, 2025-03: 1529.2, 2025-06: 1515.5, 2025-09: 1640.4, 2025-12: 1692, 2026-03: 1744.5, 2026-06: 1825.6, 2026-09: 1873.2,
Rev. CAGR: 7.90%
Rev. Trend: 96.8%
Last SUE: 0.84
Qual. Beats: 1

Warnings

Fakeout
Below Avwap Earnings

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan -2.5% 19
Feb -6.2% 26
Mar -1.6% 8
Apr -0.7% 7
May -1.3% 2
Jun -1.4% 8
Jul +3.0% 24
Aug -2.3% 6
Sep -1.2% 19
Oct -1.3% 28
Nov +4.0% 26
Dec -1.4% 26

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: IVZ

Invesco Ltd. (IVZ) is a publicly owned, large-cap global investment manager founded in 1935 and headquartered in Atlanta, Georgia, with additional offices across Asia, Europe, Africa, and North America. The firm serves a broad client base that includes retail, institutional, high-net-worth, public, corporate, and nonprofit entities, as well as pension funds, financial institutions, and sovereign wealth funds. Operating within the GICS Financials sector (Asset Management & Custody Banks sub-industry), Invesco offers equity, fixed income, commodity, multi-asset, and balanced products through mutual funds, exchange-traded funds (ETFs), and private funds.

The firm invests across global public equity and fixed income markets, as well as alternative markets such as commodities and currencies, with a stated preference for equity investments of $5 million to $15 million per company. Its equity strategies span growth and value styles across large-, mid-, and small-cap segments, while its fixed income approach covers government, municipal, and Treasury securities, convertibles, investment-grade and high-yield bonds, senior secured loans, and structured products including asset-backed, mortgage-backed, and commercial mortgage-backed securities. Invesco employs absolute return, global macro, long/short, and quantitative strategies, and trades on the NYSE under the ticker IVZ, having gone public in August 1995.

Headlines to Watch Out For
  • QQQ ETF assets hit record on sustained tech inflows
  • Active equity outflows pressure fee-based margins
  • Capital return continues via dividend and buyback program
Piotroski VR-10 (Strict) 4.5
Net Income: -78.7m TTM > 0 and > 6% of Revenue
FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.88 > 1.0
NWC/Revenue: -4.82% < 20% (prev 18.80%; Δ -23.62% < -1%)
CFO/TA 0.07 > 3% & CFO 1.88b > Net Income -78.7m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 0.91 > 1.5 & < 3
Outstanding Shares: last quarter (452.5m) vs 12m ago -0.46% < -2%
Gross Margin: 74.60% > 18% (prev 35.41%; Δ 39.19% > 0.5%)
Asset Turnover: 25.44% > 50% (prev 22.08%; Δ 3.37% > 0%)
Interest Coverage Ratio: -3.12 > 6 (EBIT TTM -284.5m / Interest Expense TTM 91.2m)
Altman Z'' 1.49
A: -0.01 (Total Current Assets 3.29b - Total Current Liabilities 3.63b) / Total Assets 27.6b
B: 0.21 (Retained Earnings 5.89b / Total Assets 27.6b)
C: -0.01 (EBIT TTM -284.5m / Avg Total Assets 28.0b)
D: 0.90 (Book Value of Equity 12.6b / Total Liabilities 14.0b)
Altman-Z'' = 1.49 = BB
What is the price of IVZ shares?

As of November 04, 2026, the stock is trading at USD 28.26 with a total of 4,452,299 shares traded. Over the past week, the price has changed by -0.60%, over one month by -7.34%, over three months by -7.96% and over the past year by +23.66%.

Current recommended Stop Loss: 26.90 (which is 4.8% or 1.4 ATR below the current price).

Is IVZ a buy, sell or hold?

has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold IVZ.

  • StrongBuy: 4
  • Buy: 2
  • Hold: 9
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the IVZ price?
Analysts Target Price 35.1 24.1%
(IVZ) - Fundamental Data Overview as of 30 October 2026
Market Cap USD = 12.6b (12.6b USD * 1.0 USD.USD)
P/E Forward = 8.8028
P/S = 1.8261
P/B = 0.9893
P/EG = 0.9008
Revenue TTM = 7.14b USD
EBIT TTM = -284.5m USD
EBITDA TTM = -175.1m USD
Long Term Debt = 10.8b USD (from longTermDebt, last fiscal year)
Short Term Debt = 66.6m USD (from shortTermDebt, last fiscal year)
Debt = 11.3b USD (corrected: LT Debt 10.8b + ST Debt 66.6m) + Leases 406.7m
Net Debt = 10.3b USD (calculated: Debt 11.3b - CCE 965.5m)
Enterprise Value = 22.9b USD (12.6b + Debt 11.3b - CCE 965.5m)
Interest Coverage Ratio = -3.12 (Ebit TTM -284.5m / Interest Expense TTM 91.2m)
EV/FCF = 12.35x (Enterprise Value 22.9b / FCF TTM 1.85b)
FCF Yield = 8.09% (FCF TTM 1.85b / Enterprise Value 22.9b)
FCF Margin = 25.98% (FCF TTM 1.85b / Revenue TTM 7.14b)
Net Margin = -1.10% (Net Income TTM -78.7m / Revenue TTM 7.14b)
Gross Margin = 74.60% ((Revenue TTM 7.14b - Cost of Revenue TTM 1.81b) / Revenue TTM)
Gross Margin QoQ = 65.64% (prev none%)
Tobins Q-Ratio = 0.83 (Enterprise Value 22.9b / Total Assets 27.6b)
Interest Expense / Debt = 0.81% (Interest Expense 91.2m / Debt 11.3b)
Taxrate = 23.35% (108.3m / 463.9m)
NOPAT = -218.1m (EBIT -284.5m * (1 - 23.35%)) [loss with tax shield]
Current Ratio = 0.91 (Total Current Assets 3.29b / Total Current Liabilities 3.63b)
Debt / Equity = 0.89 (Debt 11.3b / totalStockholderEquity, last quarter 12.6b)
 Debt / EBITDA = -58.83 (negative EBITDA) (Net Debt 10.3b / EBITDA -175.1m)
 Debt / FCF = 5.56 (Net Debt 10.3b / FCF TTM 1.85b)
Total Stockholder Equity = 12.4b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.28% (Net Income -78.7m / Total Assets 27.6b)
RoE = -0.63% (Net Income TTM -78.7m / Total Stockholder Equity 12.4b)
RoCE = -1.23% (EBIT -284.5m / Capital Employed (Equity 12.4b + L.T.Debt 10.8b))
 RoIC = -0.92% (negative operating profit) (NOPAT -218.1m / Invested Capital 23.7b)
 WACC = 6.52% (E(12.6b)/V(23.9b) * Re(11.80%) + D(11.3b)/V(23.9b) * Rd(0.81%) * (1-Tc(0.23)))
Discount Rate = 11.80% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -77.13 | Cagr: -0.35%
[DCF] Terminal Value 77.97% ; FCFF base≈1.66b ; Y1≈1.91b ; Y5≈2.80b
[DCF] Fair Price = 72.56 (EV 42.2b - Net Debt 10.3b = Equity 31.9b / Shares 439.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.71 | EPS CAGR: 22.33% | SUE: -0.48 | # QB: 0
Revenue Correlation: 96.84 | Revenue CAGR: 7.90% | SUE: 0.84 | # QB: 1
EPS current Quarter (2027-03-31): EPS=0.71 | Chg30d=-0.13% | Revisions=+17% | Analysts=10
EPS current Year (2026-12-31): EPS=2.79 | Chg30d=-0.77% | Revisions=-10% | GrowthEPS=+37.2% | GrowthRev=+15.2%
EPS next Year (2027-12-31): EPS=3.28 | Chg30d=+0.65% | Revisions=-22% | GrowthEPS=+17.8% | GrowthRev=+7.5%
[Analyst] Revisions Ratio: -11% (up=7, down=9)